Cite
Gnekow AK, Walker DA, Kandels D, et al. Corrigendum to "A European randomised controlled trial of the addition of etoposide to standard vincristine and carboplatin induction as part of an 18-month treatment programme for childhood (≤16 years) low grade glioma - A final report" [Eur J of Canc (2017) 206-225]. Eur J Cancer. 2017;90:156-157doi: 10.1016/j.ejca.2017.11.017.
Gnekow, A. K., Walker, D. A., Kandels, D., Picton, S., Giorgio Perilongo, Grill, J., Stokland, T., Sandstrom, P. E., Warmuth-Metz, M., Pietsch, T., Giangaspero, F., Schmidt, R., Faldum, A., Kilmartin, D., De Paoli, A., De Salvo, G. L. (2018). Corrigendum to "A European randomised controlled trial of the addition of etoposide to standard vincristine and carboplatin induction as part of an 18-month treatment programme for childhood (≤16 years) low grade glioma - A final report" [Eur J of Canc (2017) 206-225]. European journal of cancer (Oxford, England : 1990), 90156-157. https://doi.org/10.1016/j.ejca.2017.11.017
Gnekow, Astrid K, et al. "Corrigendum to "A European randomised controlled trial of the addition of etoposide to standard vincristine and carboplatin induction as part of an 18-month treatment programme for childhood (≤16 years) low grade glioma - A final report" [Eur J of Canc (2017) 206-225]." European journal of cancer (Oxford, England : 1990) vol. 90 (2018): 156-157. doi: https://doi.org/10.1016/j.ejca.2017.11.017
Gnekow AK, Walker DA, Kandels D, Picton S, Giorgio Perilongo, Grill J, Stokland T, Sandstrom PE, Warmuth-Metz M, Pietsch T, Giangaspero F, Schmidt R, Faldum A, Kilmartin D, De Paoli A, De Salvo GL. Corrigendum to "A European randomised controlled trial of the addition of etoposide to standard vincristine and carboplatin induction as part of an 18-month treatment programme for childhood (≤16 years) low grade glioma - A final report" [Eur J of Canc (2017) 206-225]. Eur J Cancer. 2018 Feb;90:156-157. doi: 10.1016/j.ejca.2017.11.017. Epub 2017 Dec 14. PMID: 29248309; PMCID: PMC6854447.
Copy
Download .nbib